RNA-seq
ESMO Study Identifies Potential Predictive Biomarkers to ID TNBC Patients for Therapy De-Escalation
The study analyzed several biomarkers using Oncocyte's IO score, TNBCtype, and RNA sequencing, to identify response to neoadjuvant atezolizumab.
Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features
Using a single-cell sequencing and clonal fitness mapping method, researchers compared EGFR-mutant lung cancer cell responses to EGFR inhibition or targeted protein degradation.
Advanced Gastric Cancer Multiomic Analysis Reveals New Potential Therapeutic Targets
An integrated analysis of peritoneal metastases in advanced gastric cancer patients pointed to new molecular subgroups and treatment targets.
Researchers envision combining this inflammation signature with other biomarkers like PD-L1 to better select patients for treatment with checkpoint inhibitors.
Strata Oncology Developing Integrated TMB, PD-L1, PD-L2 Test to Predict Checkpoint Inhibitor Benefit
Premium
The diagnostic company is confirming initial findings in a validation study and exploring companion diagnostic partnerships for the investigational test.